MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Prof. Dr. med. Ingo Eitel
- Trial code
- NCT06804148
- Record updated
- 3 February 2025
- Original description
Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.Read full original descriptionShow less
Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.
Inclusion: Patient is going to be treated with Myval THV; Age ≥ 18 years; Ability to give informed consent.
Exclusion: Patients with hyper sensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast media; Any condition, which in the Investigator's opinion, would preclude safe participation of patient in the registry; Patients in whom anti-platelet and/or anticoagulant therapy are contra-indicated; Pregnant and lactating women.